0001193125-16-439968.txt : 20160127 0001193125-16-439968.hdr.sgml : 20160127 20160127170201 ACCESSION NUMBER: 0001193125-16-439968 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151130 FILED AS OF DATE: 20160127 DATE AS OF CHANGE: 20160127 EFFECTIVENESS DATE: 20160127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AB CAP FUND, INC. CENTRAL INDEX KEY: 0000081443 IRS NUMBER: 132625045 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-01716 FILM NUMBER: 161365776 BUSINESS ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND, INC. DATE OF NAME CHANGE: 20110524 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND,INC DATE OF NAME CHANGE: 20040908 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN SMALL CAP GROWTH FUND INC DATE OF NAME CHANGE: 19931001 0000081443 S000034315 AB All Market Growth Portfolio C000105672 Class A ADAAX C000105673 Class C ADACX C000105674 Advisor Class ADAYX C000105675 Class R ADARX C000105676 Class K ADAKX C000105677 Class I AMAIX C000105678 Class 1 ADADX C000105679 Class 2 ADAEX C000150884 Class Z ADAZX N-Q 1 d96212dnq.htm AB CAP FUND, INC. - AB ALL MARKET GROWTH PORTFOLIO AB Cap Fund, Inc. - AB All Market Growth Portfolio

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-01716

AB CAP FUND, INC.

(Exact name of registrant as specified in charter)

1345 Avenue of the Americas, New York, New York 10105

(Address of principal executive offices) (Zip code)

Joseph J. Mantineo

AllianceBernstein L.P.

1345 Avenue of the Americas

New York, New York 10105

(Name and address of agent for service)

Registrant’s telephone number, including area code: (800) 221-5672

Date of fiscal year end: February 29, 2016

Date of reporting period: November 30, 2015

 

 

 


ITEM 1. SCHEDULE OF INVESTMENTS.


AB All Market Growth Portfolio

Consolidated Portfolio of Investments

November 30, 2015 (unaudited)

 

      Principal
Amount
(000)
       U.S. $ Value  

INFLATION-LINKED SECURITIES - 23.1%

       

United States - 23.1%

       

U.S. Treasury Inflation Index 0.125%, 4/15/19-7/15/22 (TIPS)

   U.S. $ 2,035         $ 2,009,552   

0.625%, 7/15/21 (TIPS)(a)

     611           620,126   

1.125%, 1/15/21 (TIPS)(a)

     411           426,820   

1.25%, 7/15/20 (TIPS)

     226           236,215   

1.375%, 1/15/20 (TIPS)

     101           105,800   

1.875%, 7/15/19 (TIPS)

     288           306,312   

2.125%, 1/15/19 (TIPS)

     60           63,599   
       

 

 

 

Total Inflation-Linked Securities
(cost $3,799,737)

          3,768,424   
       

 

 

 
     Shares           

INVESTMENT COMPANIES - 2.7%

       

Funds and Investment Trusts - 2.7%

       

iShares Core MSCI Emerging Markets ETF JDR
(cost $444,902)

     10,775           445,762   
       

 

 

 

SHORT-TERM INVESTMENTS - 67.5%

       

Investment Companies - 67.4%

       

AB Fixed-Income Shares, Inc. - Government STIF
Portfolio, 0.16%
(b) (c)
(cost $10,987,083)

     10,987,083           10,987,083   
       

 

 

 
     Principal
Amount
(000)
          

TIME DEPOSITS - 0.1%

       

BBH, Grand Cayman

       

(0.222)%, 12/01/15

   EUR 1           1,555   

0.005%, 12/01/15

   HKD 0        0   

0.005%, 12/01/15

   JPY 620           5,038   

0.05%, 12/01/15

   CAD 0        0^   

5.12%, 12/01/15

   ZAR 0        0^   
       

 

 

 

Total Time Deposits
(cost $6,617)

          6,593   
       

 

 

 

Total Short-Term Investments
(cost $10,993,700)

          10,993,676   
       

 

 

 

Total Investments - 93.3%
(cost $15,238,339)
(d)

          15,207,862   

Other assets less liabilities - 6.7%

          1,087,038   
       

 

 

 

Net Assets - 100.0%

        $ 16,294,900   
       

 

 

 


FUTURES

 

Type

   Number
of
Contracts
     Expiration
Month
     Original
Value
     Value at
November 30,
2015
     Unrealized
Appreciation/
(Depreciation)
 

Purchased Contracts

              

Australian 10 Yr Bond Futures

     15         December 2015       $ 1,383,047       $ 1,375,988       $ (7,059

Cocoa Futures

     1         March 2016         32,680         33,390         710   

Corn Futures

     6         March 2016         110,400         111,675         1,275   

Cotton No.2 Futures

     1         March 2016         31,150         31,320         170   

EURO STOXX 50 Futures

     42         December 2015         1,491,694         1,552,731         61,037   

Euro-Bund Futures

     30         December 2015         4,969,588         5,017,873         48,285   

Gas Oil Futures

     3         January 2016         139,025         127,800         (11,225

Gasoline Rbob Futures

     4         January 2016         229,346         220,282         (9,064

Gold Futures

     2         February 2016         226,920         213,060         (13,860

Heating Oil Futures

     1         December 2015         64,226         56,876         (7,350

Long Gilt Futures

     9         March 2016         1,590,351         1,595,818         5,467   

Mini 10 Yr JGB Futures

     25         December 2015         3,014,915         3,015,435         520   

Natural Gas Futures

     6         December 2015         151,130         134,100         (17,030

Platinum Futures

     1         January 2016         48,747         41,645         (7,102

Russell 2000 Mini Futures

     1         December 2015         116,400         119,590         3,190   

S&P 500 E-Mini Futures

     29         December 2015         2,992,324         3,015,710         23,386   

S&P Mid 400 E-Mini Futures

     2         December 2015         283,535         292,020         8,485   

Silver Futures

     1         March 2016         77,400         70,430         (6,970

Soybean Futures

     4         January 2016         179,450         176,200         (3,250

Soybean Meal Futures

     6         March 2016         180,983         172,500         (8,483

Sugar #11 Futures

     13         February 2016         216,984         217,381         397   

TOPIX Index Futures

     8         December 2015         999,777         1,028,249         28,472   

U.S. T-Note 10 Yr (CBT) Futures

     21         March 2016         2,649,938         2,655,188         5,250   

U.S. T-Note 2 Yr (CBT) Futures

     3         March 2016         652,594         652,641         47   

U.S. T-Note 5 Yr (CBT) Futures

     20         March 2016         2,372,031         2,373,594         1,563   

Wheat Futures (CBT)

     4         March 2016         104,750         95,100         (9,650
              

 

 

 
               $ 87,211   
              

 

 

 

FORWARD CURRENCY EXCHANGE CONTRACTS

 

Counterparty

   Contracts to
Deliver
(000)
     In Exchange
For
(000)
     Settlement
Date
     Unrealized
Appreciation/
(Depreciation)
 

Brown Brothers Harriman & Co.

     AUD         81         USD         56         12/15/15       $ (2,163

Brown Brothers Harriman & Co.

     CAD         63         USD         48         12/15/15         851   

Brown Brothers Harriman & Co.

     CHF         24         USD         24         12/15/15         301   

Brown Brothers Harriman & Co.

     EUR         305         USD         342         12/15/15         19,771   

Brown Brothers Harriman & Co.

     GBP         155         USD         234         12/15/15         671   

Brown Brothers Harriman & Co.

     JPY         33,533         USD         277         12/15/15         4,551   

Brown Brothers Harriman & Co.

     NOK         98         USD         11         12/15/15         66   


Counterparty

   Contracts to
Deliver
(000)
     In Exchange
For
(000)
     Settlement
Date
     Unrealized
Appreciation/
(Depreciation)
 

Brown Brothers Harriman & Co.

     USD         34         AUD         48         12/15/15       $ 565   

Brown Brothers Harriman & Co.

     USD         47         CAD         63         12/15/15         (211

Brown Brothers Harriman & Co.

     USD         184         CHF         179         12/15/15         (9,677

Brown Brothers Harriman & Co.

     USD         859         EUR         765         12/15/15         (50,582

Brown Brothers Harriman & Co.

     USD         177         GBP         116         12/15/15         (3,379

Brown Brothers Harriman & Co.

     USD         474         JPY         56,692         12/15/15         (13,094

Brown Brothers Harriman & Co.

     USD         12         NOK         98         12/15/15         (599

Brown Brothers Harriman & Co.

     USD         49         SEK         409         12/15/15         (1,725

Brown Brothers Harriman & Co.

     EUR         169         USD         181         3/18/16         2,122   

Brown Brothers Harriman & Co.

     GBP         158         USD         239         3/18/16         530   

Brown Brothers Harriman & Co.

     USD         59         CAD         78         3/18/16         (259

Brown Brothers Harriman & Co.

     USD         59         CHF         60         3/18/16         (521

Brown Brothers Harriman & Co.

     USD         381         EUR         354         3/18/16         (6,379

Brown Brothers Harriman & Co.

     USD         161         GBP         105         3/18/16         (2,734

Brown Brothers Harriman & Co.

     USD         274         JPY         33,531         3/18/16         (392

Brown Brothers Harriman & Co.

     USD         26         SEK         226         3/18/16         (36

Deutsche Bank AG

     JPY         21,780         USD         178         12/15/15         741   

HSBC BankUSA

     GBP         108         USD         164         12/15/15         1,610   

JPMorgan Chase Bank, NA

     USD         381         JPY         46,086         12/15/15         (6,585

Royal Bank of Scotland PLC

     EUR         230         USD         262         12/15/15         19,038   

UBS AG

     EUR         230         USD         253         12/15/15         10,205   

UBS AG

     USD         226         GBP         147         12/15/15         (4,532

UBS AG

     USD         276         EUR         257         3/18/16         (3,441

UBS AG

     USD         392         GBP         256         3/18/16         (6,065
                 

 

 

 
                  $ (51,352
                 

 

 

 

CENTRALLY CLEARED CREDIT DEFAULT SWAPS

 

Clearing Broker/(Exchange)

& Referenced Obligation

   Fixed Rate
(Pay)
Receive
    Implied Credit
Spread at
November 30, 2015
    Notional
Amount
(000)
     Market
Value
     Unrealized
Appreciation/
(Depreciation)
 

Sale Contracts

            

Citigroup Global Markets Inc./(INTRCONX )

            

CDX-NAIG Series 22, 5 Year
Index, 6/20/19*

     1.00     0.69   $ 350       $ 4,471       $ 917   

Morgan Stanley & Co. LLC/(INTRCONX )

            

CDX-NAHY Series 25, 5 Year
Index, 12/20/20*

     5.00        4.50        670         20,752         8,630   

CDX-NAHY Series 25, 5 Year
Index, 12/20/20*

     5.00        4.50        110         3,407         1,761   

CDX-NAHY Series 25, 5 Year
Index, 12/20/20*

     5.00        4.50        450         13,937         3,842   

CDX-NAHY Series 25, 5 Year
Index, 12/20/20*

     5.00        4.50        362         11,213         2,565   


Clearing Broker/(Exchange) & Referenced Obligation

   Fixed Rate
(Pay)
Receive
    Implied Credit
Spread at
November 30, 2015
    Notional
Amount
(000)
     Market
Value
     Unrealized
Appreciation/
(Depreciation)
 

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00     0.84   $ 140       $ 1,335       $ 368   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        160         1,526         334   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        140         1,335         233   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        260         2,479         455   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        180         1,717         203   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        210         2,002         295   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        160         1,526         118   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        500         4,768         367   

CDX-NAIG Series 25, 5 Year
Index, 12/20/20*

     1.00        0.84        610         5,816         (411

CDX-NAIG Series 24, 5 Year
Index, 6/20/20*

     1.00        0.81        240         2,489         (1,155

iTraxx Europe Crossover Series 23, 5 Year Index, 6/20/20*

     5.00        3.12      EUR   130         11,903         (102

iTraxx Europe Crossover Series 24, 5 Year Index, 12/20/20*

     5.00        2.89        130         14,484         3,516   

iTraxx Europe Crossover Series 24, 5 Year Index, 12/20/20*

     5.00        2.89        100         11,141         1,594   

iTraxx Europe Crossover Series 24, 5 Year Index, 12/20/20*

     5.00        2.89        60         6,685         661   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        270         4,869         1,813   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        110         1,984         647   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        140         2,524         446   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        90         1,623         320   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        120         2,164         335   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        170         3,065         428   

iTraxx Europe Series 24, 5 Year
Index, 12/20/20*

     1.00        0.70        920         16,591         1,767   
         

 

 

    

 

 

 
          $ 155,806       $ 29,947   
         

 

 

    

 

 

 

 

* Termination date

INFLATION (CPI) SWAPS

 

                   Rate Type        

Swap Counterparty

   Notional
Amount
(000)
     Termination
Date
     Payments
made by
the
Fund
    Payments
received
by the
Fund
    Unrealized
Appreciation/
(Depreciation)
 

Barclays Bank PLC

   $ 110         11/12/25         2.1625     CPI   $ 463   

Deutsche Bank AG

     700         10/07/25         2.155     CPI     2,796   

Deutsche Bank AG

     160         10/27/25         2.1075     CPI     1,032   

Deutsche Bank AG

     220         11/11/25         2.155     CPI     1,010   

Deutsche Bank AG

     350         11/17/25         2.165     CPI     1,461   

Goldman Sachs International

     440         11/16/25         2.1575     CPI     2,004   


                   Rate Type        

Swap Counterparty

   Notional
Amount
(000)
     Termination
Date
     Payments
made by
the
Fund
    Payments
received
by the
Fund
    Unrealized
Appreciation/
(Depreciation)
 

JPMorgan Chase Bank, NA

   $ 440         10/06/25         2.05     CPI   $ 3,839   
            

 

 

 
             $ 12,605   
            

 

 

 

 

# Variable interest rate based on the rate of inflation as determined by the Consumer Price Index (CPI).

TOTAL RETURN SWAPS

 

Counterparty & Referenced Obligation

   # of Shares
or Units
     Rate Paid/
Received
  Notional
Amount
(000)
     Maturity
Date
     Unrealized
Appreciation/
(Depreciation)
 

Receive Total Return on Reference Obligation

             

UBS AG

             

Russell 2000 Index

     38       LIBOR minus
0.70%
  $ 211         10/17/16       $ 6,734   

 

* Principal amount less than 500.
^ Less than $0.50.
(a) Position, or a portion thereof, has been segregated to collateralize exchange-traded derivatives outstanding.
(b) To obtain a copy of the fund’s financial statements, please go to the Securities and Exchange Commission’s website at www.sec.gov, or call AB at (800) 227-4618.
(c) Investment in affiliated money market mutual fund. The rate shown represents the 7-day yield as of period end.
(d) As of November 30, 2015, the cost basis of investment securities owned was substantially identical for both book and tax purposes. Gross unrealized appreciation of investments was $860 and gross unrealized depreciation of investments was $(31,337), resulting in net unrealized depreciation of $(30,477).

Currency Abbreviation:

 

AUD    -    Australian Dollar
CAD    -    Canadian Dollar
CHF    -    Swiss Franc
EUR    -    Euro
GBP    -    Great British Pound
HKD    -    Hong Kong Dollar
JPY    -    Japanese Yen
NOK    -    Norwegian Krone
SEK    -    Swedish Krona
USD    -    United States Dollar
ZAR    -    South African Rand

Glossary:

 

ASX    -    Australian Stock Exchange
CBT    -    Chicago Board of Trade
CDX-NAHY    -    North American High Yield Credit Default Swap Index
CDX-NAIG    -    North American Investment Grade Credit Default Swap Index
CPI    -    Consumer Price Index
ETF    -    Exchange Traded Fund
INTRCONX    -    Inter-Continental Exchange
JDR    -    Japanese Deposit Receipt
JGB    -    Japanese Government Bond
LIBOR    -    London Interbank Offered Rates
MSCI    -    Morgan Stanley Capital International
TIPS    -    Treasury Inflation Protected Security
TOPIX    -    Tokyo Price Index


AB All Market Growth Portfolio

November 30, 2015 (unaudited)

In accordance with U.S. GAAP regarding fair value measurements, fair value is defined as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The U.S GAAP disclosure requirements establish a framework for measuring fair value, and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-tier hierarchy of inputs is summarized below.

 

   

Level 1—quoted prices in active markets for identical investments

   

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

   

Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

The fair value of debt instruments, such as bonds, and over-the-counter derivatives is generally based on market price quotations, recently executed market transactions (where observable) or industry recognized modeling techniques and are generally classified as Level 2. Pricing vendor inputs to Level 2 valuations may include quoted prices for similar investments in active markets, interest rate curves, coupon rates, currency rates, yield curves, option adjusted spreads, default rates, credit spreads and other unique security features in order to estimate the relevant cash flows which is then discounted to calculate fair values. If these inputs are unobservable and significant to the fair value, these investments will be classified as Level 3. In addition, non-agency rated investments are classified as Level 3.

Other fixed income investments, including non-U.S. government and corporate debt, are generally valued using quoted market prices, if available, which are typically impacted by current interest rates, maturity dates and any perceived credit risk of the issuer. Additionally, in the absence of quoted market prices, these inputs are used by pricing vendors to derive a valuation based upon industry or proprietary models which incorporate issuer specific data with relevant yield/spread comparisons with more widely quoted bonds with similar key characteristics. Those investments for which there are observable inputs are classified as Level 2. Where the inputs are not observable, the investments are classified as Level 3.

The following table summarizes the valuation of the Fund’s investments by the above fair value hierarchy levels as of November 30, 2015:

 

Investments in Securities

   Level 1     Level 2     Level 3     Total  

Assets:

        

Investment Companies

   $ 445,762      $ – 0  –    $ – 0  –    $ 445,762   

Inflation-Linked Securities

     – 0  –      3,768,424        – 0  –      3,768,424   

Short-Term Investments:

        

Investment Companies

     10,987,083        – 0  –      – 0  –      10,987,083   

Time Deposits

     – 0  –      6,593        – 0  –      6,593   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments in Securities

     11,432,845        3,775,017        – 0  –      15,207,862   

Other Financial Instruments*:

        

Assets

        

Futures

     98,745        89,509        – 0  –      188,254   

Forward Currency Exchange Contracts

     – 0  –      61,022        – 0  –      61,022   

Centrally Cleared Credit Default Swaps

     – 0  –      31,615        – 0  –      31,615   

Inflation (CPI) Swaps

     – 0  –      12,605        – 0  –      12,605   

Total Return Swaps

     – 0  –      6,734        – 0  –      6,734   

Liabilities

        

Futures

     (101,043     – 0  –      – 0  –      (101,043

Forward Currency Exchange Contracts

     – 0  –      (112,374     – 0  –      (112,374

Centrally Cleared Credit Default Swaps

     – 0  –      (1,668     – 0  –      (1,668
  

 

 

   

 

 

   

 

 

   

 

 

 

Total^

   $     11,430,547      $     3,862,460      $             – 0  –    $     15,293,007   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Other financial instruments are derivative instruments, such as futures, forwards and swaps, which are valued at the unrealized appreciation/depreciation on the instrument.
^ There were no transfers between any levels during the reporting period.


The Fund recognizes all transfers between levels of the fair value hierarchy assuming the financial instrument was transferred at the beginning of the reporting period.

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value.

The Adviser has established a Valuation Committee (the “Committee”) which is responsible for overseeing the pricing and valuation of all securities held in the Portfolios. The Committee operates under pricing and valuation policies and procedures established by the Adviser and approved by the Board, including Pricing Policies which set forth the mechanisms and processes to be employed on a daily basis to implement these policies and procedures. In particular, the Pricing Policies describe how to determine market quotations for securities and other instruments. The Committee’s responsibilities include: 1) fair value and liquidity determinations (and oversight of any third parties to whom any responsibility for fair value and liquidity determinations is delegated), and 2) regular monitoring of the Adviser’s pricing and valuation policies and procedures and modification or enhancement of these policies and procedures (or recommendation of the modification of these policies and procedures) as the Committee believes appropriate.

The Committee is also responsible for monitoring the implementation of the Pricing Policies by the Adviser’s Pricing Group (the “Pricing Group”) and a third party which performs certain pricing functions in accordance with the Pricing Policies. The Pricing Group is responsible for the oversight of the third party on a day-to-day basis. The Committee and the Pricing Group perform a series of activities to provide reasonable assurance of the accuracy of prices including: 1) periodic vendor due diligence meetings, review of methodologies, new developments, process at vendors, 2) daily and monthly multi-source pricing compares, reviewed and submitted to the Committee, and 3) daily review of unpriced, stale, and variance reports with exceptions reviewed by senior management and the Committee.

In addition, several processes outside of the pricing process are used to monitor valuation issues including: 1) performance and performance attribution reports are monitored for anomalous impacts based upon benchmark performance, and 2) portfolio managers review all portfolios for performance and analytics (which are generated using the Adviser’s prices).


ITEM 2. CONTROLS AND PROCEDURES.

(a) The registrant’s principal executive officer and principal financial officer have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective at the reasonable assurance level based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this document.

(b) There were no significant changes in the registrant’s internal control over financial reporting that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

ITEM 3. EXHIBITS.

The following exhibits are attached to this Form N-Q:

 

EXHIBIT NO. 

 

DESCRIPTION OF EXHIBIT

11 (a) (1)   Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 (a) (2)   Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant): AB Cap Fund, Inc.

 

By:   /s/    Robert M. Keith
  Robert M. Keith
  President
Date:   January 20, 2016

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By:   /s/    Robert M. Keith
  Robert M. Keith
  President
Date:   January 20, 2016
By:   /s/    Joseph J. Mantineo
  Joseph J. Mantineo
  Treasurer and Chief Financial Officer
Date:   January 20, 2016
EX-99.CERT 2 d96212dex99cert.htm CERTIFICATIONS Certifications

Exhibit 11 (a) (1)

CERTIFICATIONS

I, Robert M. Keith, certify that:

1. I have reviewed this report on Form N-Q of AB Cap Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/    Robert M. Keith
Robert M. Keith
President

Date: January 20, 2016


Exhibit 11 (a) (2)

CERTIFICATIONS

I, Joseph J. Mantineo, certify that:

1. I have reviewed this report on Form N-Q of AB Cap Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/    Joseph J. Mantineo
Joseph J. Mantineo
Treasurer and Chief Financial Officer

Date: January 20, 2016